Compare HCA Health Inc (HCA) vs Kraft Heinz Co (KHC) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
HCA Health Inc vs Kraft Heinz Co — how do they compare? HCA Health Inc trades at $451.09 (market cap $96.35B), while Kraft Heinz Co trades at $22.27 (market cap $26.66B). The key difference: HCA Health Inc is far larger — about 3.6× Kraft Heinz Co's market cap, and Kraft Heinz Co pays the higher dividend (7.12%). Which is the better fit depends on your goals — on Pluang, investors hold HCA Health Inc for 76 Days and Kraft Heinz Co for 129 Days on average.
| HCA | KHC | |
|---|---|---|
Market Cap | $96.35B | $26.66B |
Volume | 1,079,453 | 31,300,109 |
Sector | Health | Consumer Staples |
52-Week High | $545.13 | $27.62 |
52-Week Low | $361.32 | $21.21 |
Typical Hold Time | 76 Days | 129 Days |
Enterprise Value | $146.88B | $42.98B |
Dividend Yield | 0.7% | 7.12% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
HCA Healthcare trades at $445.01, up 1.33% today, with a bullish technical signal and strong earnings beats in recent quarters. Revenue grew to $75.60 billion in 2025, with a net income margin of 8.77%. The stock is supported by a consensus analyst price target of $461.12 and a 63% buy rating. Recent news includes an upcoming Q3 2026 earnings call and completion of the College of Health Care Professions acquisition, highlighting growth initiatives amid ongoing legal investigations.
Outlook remains positive given solid demand and cost controls, but risks include payer-mix pressure and regulatory scrutiny. The stock offers value with a P/E of 14.92 and upside to the price target, though high debt levels and legal overhangs warrant caution for investors seeking stable healthcare exposure.
Kraft Heinz (KHC) trades at $22.48, up 2.27% today, but remains in a bearish technical trend. The company reported a net loss of $5.85 billion in 2025 due to a significant impairment charge, though recent quarters have beaten EPS estimates. Operating cash flow remains strong at $4.46 billion, supporting a $0.40 dividend. News highlights focus on brand revitalization efforts, such as new Philadelphia cream cheese flavors, as part of a broader turnaround strategy.
The outlook is mixed: valuation metrics like P/B of 0.74 suggest potential undervaluation, but persistent net losses and high debt pose risks. Analyst sentiment is cautious with a consensus price target of $24.50. The stock's near-term direction hinges on successful execution of cost management and volume recovery initiatives amid competitive pressures.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About HCA Health Inc
HCA Healthcare is a Nashville-based healthcare provider organization operating the largest collection of acute-care hospitals in the U.S. As of December 2021, the firm owned and operated 182 hospitals, 125 freestanding outpatient surgery centers, and a broad network of physician offices, urgent care clinics, and freestanding emergency rooms across nearly 20 states and a small foothold in England.
Read more on HCA →About Kraft Heinz Co
In July 2015, Kraft merged with Heinz to create the third-largest food and beverage manufacturer in North America behind PepsiCo and Nestle and the fifth-largest player in the world. Beyond its namesake brands, the combined firm's portfolio includes Oscar Mayer, Velveeta, and Philadelphia. Outside North America, the firm's global reach includes a distribution network in Europe and emerging markets that drive around one fifth of its consolidated sales base, as its products are sold in more than 190 countries and territories.
Read more on KHC →
